Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 302

1.

Understanding people's 'unrealistic optimism' about clinical research participation.

Cho HL, Miller DG, Kim SYH.

J Med Ethics. 2019 Aug 31. pii: medethics-2019-105377. doi: 10.1136/medethics-2019-105377. [Epub ahead of print]

PMID:
31473653
2.

Ethical Acceptability of Postrandomization Consent in Pragmatic Clinical Trials.

Miller DG, Kim SYH, Li X, Dickert NW, Flory J, Runge CP, Relton C.

JAMA Netw Open. 2018 Dec 7;1(8):e186149. doi: 10.1001/jamanetworkopen.2018.6149.

3.

Not one Brexit: How local context and social processes influence policy analysis.

Ge J, Polhill JG, Matthews KB, Miller DG, Spencer M.

PLoS One. 2018 Dec 17;13(12):e0208451. doi: 10.1371/journal.pone.0208451. eCollection 2018.

4.

GGC Repeat Expansion and Exon 1 Methylation of XYLT1 Is a Common Pathogenic Variant in Baratela-Scott Syndrome.

LaCroix AJ, Stabley D, Sahraoui R, Adam MP, Mehaffey M, Kernan K, Myers CT, Fagerstrom C, Anadiotis G, Akkari YM, Robbins KM, Gripp KW, Baratela WAR, Bober MB, Duker AL, Doherty D, Dempsey JC, Miller DG, Kircher M, Bamshad MJ, Nickerson DA; University of Washington Center for Mendelian Genomics, Mefford HC, Sol-Church K.

Am J Hum Genet. 2019 Jan 3;104(1):35-44. doi: 10.1016/j.ajhg.2018.11.005. Epub 2018 Dec 13.

5.
6.

Response to: 'Dementia and advance directives: some empirical and normative concerns' by Jongsma et al.

Kim SYH, Miller DG, Dresser R.

J Med Ethics. 2019 Feb;45(2):95-96. doi: 10.1136/medethics-2018-105031. Epub 2018 Aug 6. No abstract available.

PMID:
30082374
7.

Small noncoding RNAs in FSHD2 muscle cells reveal both DUX4- and SMCHD1-specific signatures.

Lim JW, Wong CJ, Yao Z, Tawil R, van der Maarel SM, Miller DG, Tapscott SJ, Filippova GN.

Hum Mol Genet. 2018 Aug 1;27(15):2644-2657. doi: 10.1093/hmg/ddy173.

8.

Reduced Computed Tomography Use in the Emergency Department Evaluation of Headache Was Not Followed by Increased Death or Missed Diagnosis.

Miller DG, Vakkalanka P, Moubarek ML, Lee S, Mohr NM.

West J Emerg Med. 2018 Mar;19(2):319-326. doi: 10.5811/westjem.2017.12.34886. Epub 2018 Feb 26.

9.

Early estimates of cancer incidence for 2015: Expanding to include estimates for white and black races.

Lewis DR, Chen HS, Cockburn MG, Wu XC, Stroup AM, Midthune DN, Zou Z, Krapcho MF, Miller DG, Feuer EJ.

Cancer. 2018 May 15;124(10):2192-2204. doi: 10.1002/cncr.31315. Epub 2018 Mar 6.

10.

Advance euthanasia directives: a controversial case and its ethical implications.

Miller DG, Dresser R, Kim SYH.

J Med Ethics. 2019 Feb;45(2):84-89. doi: 10.1136/medethics-2017-104644. Epub 2018 Mar 3.

PMID:
29502099
11.

Beyond Open Communication: A Call for Partnership Between Clinical Ethics and Research Ethics Committees.

Cho HL, Miller DG, Grady C.

Am J Bioeth. 2018 Jan;18(1):52-54. doi: 10.1080/15265161.2017.1401171. No abstract available.

12.

MRI change metrics of facioscapulohumeral muscular dystrophy: Stir and T1.

Ferguson MR, Poliachik SL, Budech CB, Gove NE, Carter GT, Wang LH, Miller DG, Shaw DWW, Friedman SD.

Muscle Nerve. 2018 Jun;57(6):905-912. doi: 10.1002/mus.26038. Epub 2018 Mar 3.

PMID:
29236297
13.

Epigenetic memory via concordant DNA methylation is inversely correlated to developmental potential of mammalian cells.

Choi M, Genereux DP, Goodson J, Al-Azzawi H, Allain SQ, Simon N, Palasek S, Ware CB, Cavanaugh C, Miller DG, Johnson WC, Sinclair KD, Stöger R, Laird CD.

PLoS Genet. 2017 Nov 6;13(11):e1007060. doi: 10.1371/journal.pgen.1007060. eCollection 2017 Nov.

14.
15.

Risks of Clinical Research Must Be Reasonable and Necessary.

Miller DG, Kim SYH.

Am J Bioeth. 2017 Oct;17(10):79-81. doi: 10.1080/15265161.2017.1365200. No abstract available.

16.

Considering Weight Loss Programs and Public Health Partnerships in American Evangelical Protestant Churches.

Miller DG.

J Relig Health. 2018 Jun;57(3):901-914. doi: 10.1007/s10943-017-0451-8.

PMID:
28712020
17.
18.

Early estimates of SEER cancer incidence, 2014.

Lewis DR, Chen HS, Cockburn MG, Wu XC, Stroup AM, Midthune DN, Zou Z, Krapcho MF, Miller DG, Feuer EJ.

Cancer. 2017 Jul 1;123(13):2524-2534. doi: 10.1002/cncr.30630. Epub 2017 Feb 14.

19.

Underperforming Big Ideas in Biomedical Research.

Miller DG, Sittig DF.

JAMA. 2017 Jan 17;317(3):321-322. doi: 10.1001/jama.2016.19997. No abstract available.

PMID:
28114546
20.

Retinal Surgery in Ambulatory Surgery Centers versus Hospital Outpatient Departments.

Sciulli H, Miller CW, Rao LJ, Hornik JH, Rowland DY, Miller DG.

Ophthalmol Retina. 2017 Nov - Dec;1(6):563-564. doi: 10.1016/j.oret.2017.01.013. Epub 2017 Mar 23. No abstract available.

PMID:
31047457
21.

Formant Tuning and Feedback in the Male Passaggio.

Ritzerfeld WGJ, Miller DG.

J Voice. 2017 Jul;31(4):506.e7-506.e17. doi: 10.1016/j.jvoice.2016.10.006. Epub 2016 Nov 2.

PMID:
27816356
22.

A Human Pluripotent Stem Cell Model of Facioscapulohumeral Muscular Dystrophy-Affected Skeletal Muscles.

Caron L, Kher D, Lee KL, McKernan R, Dumevska B, Hidalgo A, Li J, Yang H, Main H, Ferri G, Petek LM, Poellinger L, Miller DG, Gabellini D, Schmidt U.

Stem Cells Transl Med. 2016 Sep;5(9):1145-61. doi: 10.5966/sctm.2015-0224. Epub 2016 May 23.

23.

A cross sectional study of two independent cohorts identifies serum biomarkers for facioscapulohumeral muscular dystrophy (FSHD).

Petek LM, Rickard AM, Budech C, Poliachik SL, Shaw D, Ferguson MR, Tawil R, Friedman SD, Miller DG.

Neuromuscul Disord. 2016 Jul;26(7):405-13. doi: 10.1016/j.nmd.2016.04.012. Epub 2016 Apr 22.

24.

Preliminary estimates of SEER cancer incidence for 2013.

Lewis DR, Chen HS, Cockburn M, Wu XC, Stroup AM, Midthune DN, Krapcho MF, Miller DG, Penberthy L, Feuer EJ.

Cancer. 2016 May 15;122(10):1579-87. doi: 10.1002/cncr.29953. Epub 2016 Mar 15.

25.

Can Simulation Measure Differences in Task-Switching Ability Between Junior and Senior Emergency Medicine Residents?

Smith D, Miller DG, Cukor J.

West J Emerg Med. 2016 Mar;17(2):149-52. doi: 10.5811/westjem.2015.12.28269. Epub 2016 Feb 10.

28.

Standing Together Fixing the Drug Quality and Security Act.

Miller DG.

Int J Pharm Compd. 2015 Mar-Apr;19(2):104-6. No abstract available.

PMID:
26685490
29.

U.S. FOOD AND DRUG ADMINISTRATION PROPOSED GUIDANCE DOCUMENT: Compounding Animal Drugs from Bulk Substances.

Miller DG.

Int J Pharm Compd. 2015 Jul-Aug;19(4):303-5. No abstract available.

PMID:
26625566
30.

The contribution of seed dispersers to tree species diversity in tropical rainforests.

Kakishima S, Morita S, Yoshida K, Ishida A, Hayashi S, Asami T, Ito H, Miller DG 3rd, Uehara T, Mori S, Hasegawa E, Matsuura K, Kasuya E, Yoshimura J.

R Soc Open Sci. 2015 Oct 14;2(10):150330. doi: 10.1098/rsos.150330. eCollection 2015 Oct.

31.

Effect of Regulatory Requirement for Patient-Specific Prescriptions for Off-Label Medications on the Use of Intravitreal Bevacizumab.

Holfinger S, Miller AG, Rao LJ, Rowland DY, Hornik JH, Miller DG.

JAMA Ophthalmol. 2016 Jan;134(1):45-8. doi: 10.1001/jamaophthalmol.2015.4331.

PMID:
26540671
32.

The origin and genetic differentiation of the socially parasitic aphid Tamalia inquilinus.

Miller DG 3rd, Lawson SP, Rinker DC, Estby H, Abbot P.

Mol Ecol. 2015 Nov;24(22):5751-66. doi: 10.1111/mec.13423. Epub 2015 Nov 11.

PMID:
26460808
33.

Endogenous DUX4 expression in FSHD myotubes is sufficient to cause cell death and disrupts RNA splicing and cell migration pathways.

Rickard AM, Petek LM, Miller DG.

Hum Mol Genet. 2015 Oct 15;24(20):5901-14. doi: 10.1093/hmg/ddv315. Epub 2015 Aug 5.

34.

VISA--Vector Integration Site Analysis server: a web-based server to rapidly identify retroviral integration sites from next-generation sequencing.

Hocum JD, Battrell LR, Maynard R, Adair JE, Beard BC, Rawlings DJ, Kiem HP, Miller DG, Trobridge GD.

BMC Bioinformatics. 2015 Jul 7;16:212. doi: 10.1186/s12859-015-0653-6.

35.

Toward a consensus on symbolic notation of harmonics, resonances, and formants in vocalization.

Titze IR, Baken RJ, Bozeman KW, Granqvist S, Henrich N, Herbst CT, Howard DM, Hunter EJ, Kaelin D, Kent RD, Kreiman J, Kob M, Löfqvist A, McCoy S, Miller DG, Noé H, Scherer RC, Smith JR, Story BH, Švec JG, Ternström S, Wolfe J.

J Acoust Soc Am. 2015 May;137(5):3005-7. doi: 10.1121/1.4919349. No abstract available.

36.

Compounding legislation: focus shifts to states.

Miller DG.

Int J Pharm Compd. 2014 Nov-Dec;18(6):470-2. No abstract available.

PMID:
25906623
37.

Inter-individual differences in CpG methylation at D4Z4 correlate with clinical variability in FSHD1 and FSHD2.

Lemmers RJ, Goeman JJ, van der Vliet PJ, van Nieuwenhuizen MP, Balog J, Vos-Versteeg M, Camano P, Ramos Arroyo MA, Jerico I, Rogers MT, Miller DG, Upadhyaya M, Verschuuren JJ, Lopez de Munain Arregui A, van Engelen BG, Padberg GW, Sacconi S, Tawil R, Tapscott SJ, Bakker B, van der Maarel SM.

Hum Mol Genet. 2015 Feb 1;24(3):659-69. doi: 10.1093/hmg/ddu486. Epub 2014 Sep 25.

38.

U.S. Food and Drug Administration requests for input on HR 3204 enactment: the Drug Quality and Security Act of 2013.

Miller DG.

Int J Pharm Compd. 2014 Jan-Feb;18(1):35-6. No abstract available.

PMID:
24881338
39.

IACP's continuing support of compounding pharmacists: letter to the FDA concerning 503B outsourcing facilities.

Miller DG.

Int J Pharm Compd. 2014 Mar-Apr;18(2):117-8. No abstract available.

PMID:
24881114
40.

Facioscapulohumeral Muscular Dystrophy.

Lemmers RJLF, Miller DG, van der Maarel SM.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019.
1999 Mar 8 [updated 2014 Mar 20].

41.

Fine-tuned bee-flower coevolutionary state hidden within multiple pollination interactions.

Shimizu A, Dohzono I, Nakaji M, Roff DA, Miller DG 3rd, Osato S, Yajima T, Niitsu S, Utsugi N, Sugawara T, Yoshimura J.

Sci Rep. 2014 Feb 5;4:3988. doi: 10.1038/srep03988.

42.

2013 State Compounding Legislation Tracker.

Miller DG.

Int J Pharm Compd. 2013 Sep-Oct;17(5):375-8. No abstract available.

PMID:
24459782
43.

Scurvy: malnourishment in the land of plenty.

Kluesner NH, Miller DG.

J Emerg Med. 2014 Apr;46(4):530-2. doi: 10.1016/j.jemermed.2013.09.027. Epub 2014 Jan 17. No abstract available.

PMID:
24440620
44.
45.

International Academy of Compounding Pharmacists' legislative/regulatory update.

Miller DG.

Int J Pharm Compd. 2013 May-Jun;17(3):206. No abstract available.

PMID:
24046936
46.

Wnt/β-catenin signaling suppresses DUX4 expression and prevents apoptosis of FSHD muscle cells.

Block GJ, Narayanan D, Amell AM, Petek LM, Davidson KC, Bird TD, Tawil R, Moon RT, Miller DG.

Hum Mol Genet. 2013 Dec 1;22(23):4661-72. doi: 10.1093/hmg/ddt314. Epub 2013 Jul 2.

47.

Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial.

Bressler SB, Qin H, Melia M, Bressler NM, Beck RW, Chan CK, Grover S, Miller DG; Diabetic Retinopathy Clinical Research Network.

JAMA Ophthalmol. 2013 Aug;131(8):1033-40. doi: 10.1001/jamaophthalmol.2013.4154.

48.

Longitudinal features of STIR bright signal in FSHD.

Friedman SD, Poliachik SL, Otto RK, Carter GT, Budech CB, Bird TD, Miller DG, Shaw DW.

Muscle Nerve. 2014 Feb;49(2):257-60.

PMID:
23720194
49.

International Academy of Compounding Pharmacists' recommendations for state-based legislative and regulatory initiatives.

Miller DG.

Int J Pharm Compd. 2013 Jan-Feb;17(1):48-9. No abstract available.

PMID:
23627246
50.

Legislative/regulatory update from the International Academy of Compounding Pharmacists.

Miller DG.

Int J Pharm Compd. 2012 Nov-Dec;16(6):476-8. No abstract available.

PMID:
23259363

Supplemental Content

Loading ...
Support Center